Notice of meeting to the Ordinary and Extraordinary General Meeting dated May 25, 2023 The shareholders of INVENTIVA are informed that the Ordinary and Extraordinary General. | April 17, 2023
Daix (France), Long Island City (New York, United States), April 28, 2022 - Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small